Juan Gimenez

6PUBLICATIONS
28CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 15, 2026
Baseline Tumor-Specific Prognosis in Early-Stage Hepatocellular Carcinoma: Time-Dependent Role of Biomarker Profile and Modified ALBI Grade.

|May 05, 2026
Consortium on Bridging Radiation Segmentectomy (COBRAS): A Multicenter Study of Complete Pathologic Necrosis in Hepatocellular Carcinoma.

|Apr 20, 2026
Radioembolization (90Y) achieves higher response rates and reduces progression risk compared with DEB-TACE in hepatocellular carcinoma.

|Jan 10, 2026
Understanding Current Trends and Advances in Transarterial Radioembolization Dosimetry.

Shamar Young, Kiyon Naser-Tavakolian, Abin Sajan

|Sep 13, 2025
Contemporary Clinical Utilization of Radioembolization with Immune Checkpoint Inhibitors as First-Line Treatment in HCC: Real-World Report on Safety and Outcomes.

Kelley G Núñez, Tyler Sandow, Alexandre Grahovac

|Jul 29, 2024
Yttrium-90 Induces an Effector Memory Response with Neoantigen Clonotype Expansion: Implications for Immunotherapy.

Kelley Núñez, Tyler Sandow, Juan Gimenez

Pageof 1

Frequent Collaborators

4 joint publications

Ari J Cohen

4 joint publications

Paul Thevenot

3 joint publications

Kelley Núñez

3 joint publications

Tyler Sandow